Associated Papers
The molecular hallmarks of primary and secondary vitreoretinal lymphoma.
Bonzheim I et al.
Blood Advances, 2022
34448823 (PubMed )
Supplement: advancesADV2021004212-suppl1.pdf
T Cell Defects: New Insights Into the Primary Resistance Factor to CD19/CD22 Cocktail CAR T-Cell Immunotherapy in Diffuse Large B-Cell Lymphoma.
Wang J et al.
Frontiers in Immunology, 2022
35572515 (PubMed )
Supplement: Table_2.xlsx › S5
Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets.
Karube K et al.
Leukemia, 2018
28804123 (PubMed )
Supplement: leu2017251x2.xlsx › Table_S15
Select a paper to view details